Cargando…
Prevalence of Extensively Drug Resistant Tuberculosis among Archived Multidrug Resistant Tuberculosis Isolates in Zimbabwe
We conducted a cross-sectional study of second line drug resistance patterns and genetic diversity of MDR-TB isolates archived at the BRTI-TB Laboratory, Harare, between January 2007 and December 2011. DSTs were performed for second line antituberculosis drugs. XDR-TB strains were defined as MDR-TB...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054961/ https://www.ncbi.nlm.nih.gov/pubmed/24967101 http://dx.doi.org/10.1155/2014/349141 |
_version_ | 1782320573059170304 |
---|---|
author | Sagonda, Tichaona Mupfumi, Lucy Manzou, Rumbidzai Makamure, Beauty Tshabalala, Mqondisi Gwanzura, Lovemore Mason, Peter Mutetwa, Reggie |
author_facet | Sagonda, Tichaona Mupfumi, Lucy Manzou, Rumbidzai Makamure, Beauty Tshabalala, Mqondisi Gwanzura, Lovemore Mason, Peter Mutetwa, Reggie |
author_sort | Sagonda, Tichaona |
collection | PubMed |
description | We conducted a cross-sectional study of second line drug resistance patterns and genetic diversity of MDR-TB isolates archived at the BRTI-TB Laboratory, Harare, between January 2007 and December 2011. DSTs were performed for second line antituberculosis drugs. XDR-TB strains were defined as MDR-TB strains with resistance to either kanamycin and ofloxacin or capreomycin and ofloxacin. Strain types were identified by spoligotyping. No resistance to any second line drugs was shown in 73% of the isolates, with 23% resistant to one or two drugs but not meeting the definition of XDR-TB. A total of 26 shared types were identified, and 18 (69%) matched preexisting shared types in the current published spoligotype databases. Of the 11 out of 18 clustered SITs, 4 predominant (>6 isolates per shared type) were identified. The most and least abundant types were SIT 1468 (LAM 11-ZWE) with 12 (18%) isolates and SIT 53 (T1) with 6 (9%) isolates, respectively. XDR-TB strains are rare in Zimbabwe, but the high proportion of “pre-XDR-TB” strains and treatment failure cases is of concern. The genetic diversity of the MDR-TB strains showed no significant association between SITs and drug resistance. |
format | Online Article Text |
id | pubmed-4054961 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-40549612014-06-25 Prevalence of Extensively Drug Resistant Tuberculosis among Archived Multidrug Resistant Tuberculosis Isolates in Zimbabwe Sagonda, Tichaona Mupfumi, Lucy Manzou, Rumbidzai Makamure, Beauty Tshabalala, Mqondisi Gwanzura, Lovemore Mason, Peter Mutetwa, Reggie Tuberc Res Treat Research Article We conducted a cross-sectional study of second line drug resistance patterns and genetic diversity of MDR-TB isolates archived at the BRTI-TB Laboratory, Harare, between January 2007 and December 2011. DSTs were performed for second line antituberculosis drugs. XDR-TB strains were defined as MDR-TB strains with resistance to either kanamycin and ofloxacin or capreomycin and ofloxacin. Strain types were identified by spoligotyping. No resistance to any second line drugs was shown in 73% of the isolates, with 23% resistant to one or two drugs but not meeting the definition of XDR-TB. A total of 26 shared types were identified, and 18 (69%) matched preexisting shared types in the current published spoligotype databases. Of the 11 out of 18 clustered SITs, 4 predominant (>6 isolates per shared type) were identified. The most and least abundant types were SIT 1468 (LAM 11-ZWE) with 12 (18%) isolates and SIT 53 (T1) with 6 (9%) isolates, respectively. XDR-TB strains are rare in Zimbabwe, but the high proportion of “pre-XDR-TB” strains and treatment failure cases is of concern. The genetic diversity of the MDR-TB strains showed no significant association between SITs and drug resistance. Hindawi Publishing Corporation 2014 2014-05-20 /pmc/articles/PMC4054961/ /pubmed/24967101 http://dx.doi.org/10.1155/2014/349141 Text en Copyright © 2014 Tichaona Sagonda et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Sagonda, Tichaona Mupfumi, Lucy Manzou, Rumbidzai Makamure, Beauty Tshabalala, Mqondisi Gwanzura, Lovemore Mason, Peter Mutetwa, Reggie Prevalence of Extensively Drug Resistant Tuberculosis among Archived Multidrug Resistant Tuberculosis Isolates in Zimbabwe |
title | Prevalence of Extensively Drug Resistant Tuberculosis among Archived Multidrug Resistant Tuberculosis Isolates in Zimbabwe |
title_full | Prevalence of Extensively Drug Resistant Tuberculosis among Archived Multidrug Resistant Tuberculosis Isolates in Zimbabwe |
title_fullStr | Prevalence of Extensively Drug Resistant Tuberculosis among Archived Multidrug Resistant Tuberculosis Isolates in Zimbabwe |
title_full_unstemmed | Prevalence of Extensively Drug Resistant Tuberculosis among Archived Multidrug Resistant Tuberculosis Isolates in Zimbabwe |
title_short | Prevalence of Extensively Drug Resistant Tuberculosis among Archived Multidrug Resistant Tuberculosis Isolates in Zimbabwe |
title_sort | prevalence of extensively drug resistant tuberculosis among archived multidrug resistant tuberculosis isolates in zimbabwe |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054961/ https://www.ncbi.nlm.nih.gov/pubmed/24967101 http://dx.doi.org/10.1155/2014/349141 |
work_keys_str_mv | AT sagondatichaona prevalenceofextensivelydrugresistanttuberculosisamongarchivedmultidrugresistanttuberculosisisolatesinzimbabwe AT mupfumilucy prevalenceofextensivelydrugresistanttuberculosisamongarchivedmultidrugresistanttuberculosisisolatesinzimbabwe AT manzourumbidzai prevalenceofextensivelydrugresistanttuberculosisamongarchivedmultidrugresistanttuberculosisisolatesinzimbabwe AT makamurebeauty prevalenceofextensivelydrugresistanttuberculosisamongarchivedmultidrugresistanttuberculosisisolatesinzimbabwe AT tshabalalamqondisi prevalenceofextensivelydrugresistanttuberculosisamongarchivedmultidrugresistanttuberculosisisolatesinzimbabwe AT gwanzuralovemore prevalenceofextensivelydrugresistanttuberculosisamongarchivedmultidrugresistanttuberculosisisolatesinzimbabwe AT masonpeter prevalenceofextensivelydrugresistanttuberculosisamongarchivedmultidrugresistanttuberculosisisolatesinzimbabwe AT mutetwareggie prevalenceofextensivelydrugresistanttuberculosisamongarchivedmultidrugresistanttuberculosisisolatesinzimbabwe |